BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27232185)

  • 1. Tuberculosis, before and after Antiretroviral Therapy among HIV-Infected Children in Nigeria: What Are the Risk Factors?
    Anígilájé EA; Aderibigbe SA; Adeoti AO; Nweke NO
    PLoS One; 2016; 11(5):e0156177. PubMed ID: 27232185
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical burden of tuberculosis among human immunodeficiency virus-infected children in Western Kenya and the impact of combination antiretroviral treatment.
    Braitstein P; Nyandiko W; Vreeman R; Wools-Kaloustian K; Sang E; Musick B; Sidle J; Yiannoutsos C; Ayaya S; Carter EJ
    Pediatr Infect Dis J; 2009 Jul; 28(7):626-32. PubMed ID: 19451858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.
    Abuogi LL; Mwachari C; Leslie HH; Shade SB; Otieno J; Yienya N; Sanguli L; Amukoye E; Cohen CR
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1291-7. PubMed ID: 24025380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe manifestations of extrapulmonary tuberculosis in HIV-infected children initiating antiretroviral therapy before 2 years of age.
    Walters E; Duvenhage J; Draper HR; Hesseling AC; Van Wyk SS; Cotton MF; Rabie H
    Arch Dis Child; 2014 Nov; 99(11):998-1003. PubMed ID: 24938535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of incident tuberculosis on immunological response of HIV patients on highly active anti-retroviral therapy at the university of Gondar hospital, northwest Ethiopia: a retrospective follow-up study.
    Assefa A; Gelaw B; Getnet G; Yitayew G
    BMC Infect Dis; 2014 Aug; 14():468. PubMed ID: 25164855
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and predictors of tuberculosis among HIV-infected adults after initiation of antiretroviral therapy in Nigeria, 2004-2012.
    Pathmanathan I; Dokubo EK; Shiraishi RW; Agolory SG; Auld AF; Onotu D; Odafe S; Dalhatu I; Abiri O; Debem HC; Bashorun A; Ellerbrock T
    PLoS One; 2017; 12(3):e0173309. PubMed ID: 28282390
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Incidence of tuberculosis among HIV infected individuals on long term antiretroviral therapy in private healthcare sector in Pune, Western India.
    Dravid A; Natarajan K; Medisetty M; Gawali R; Mahajan U; Kulkarni M; Saraf C; Ghanekar C; Kore S; Rathod N; Dravid M
    BMC Infect Dis; 2019 Aug; 19(1):714. PubMed ID: 31409289
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis incidence rate and risk factors among HIV-infected adults with access to antiretroviral therapy.
    Liu E; Makubi A; Drain P; Spiegelman D; Sando D; Li N; Chalamilla G; Sudfeld CR; Hertzmark E; Fawzi WW
    AIDS; 2015 Jul; 29(11):1391-9. PubMed ID: 26091295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.
    Chamla DD; Asadu C; Davies A; de Wagt A; Ilesanmi O; Adeyinka D; Adejuyigbe E
    J Int AIDS Soc; 2015; 18(Suppl 6):20251. PubMed ID: 26639112
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV virological non-suppression and its associated factors in children on antiretroviral therapy at a major treatment centre in Southern Ghana: a cross-sectional study.
    Afrane AKA; Goka BQ; Renner L; Yawson AE; Alhassan Y; Owiafe SN; Agyeman S; Sagoe KWC; Kwara A
    BMC Infect Dis; 2021 Aug; 21(1):731. PubMed ID: 34340689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tuberculosis among HIV-infected population: incidence and risk factors in rural Tanzania.
    Said K; Verver S; Kalingonji A; Lwilla F; Mkopi A; Charalambous S; Reither K
    Afr Health Sci; 2017 Mar; 17(1):208-215. PubMed ID: 29026395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tuberculosis after one year of combination antiretroviral therapy in Nigeria: a retrospective cohort study.
    Akanbi MO; Achenbach CJ; Feinglass J; Taiwo B; Onu A; Pho MT; Agbaji O; Kanki P; Murphy RL
    AIDS Res Hum Retroviruses; 2013 Jun; 29(6):931-7. PubMed ID: 23316724
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of HIV and antiretroviral therapy on TB risk in children: a systematic review and meta-analysis.
    Dodd PJ; Prendergast AJ; Beecroft C; Kampmann B; Seddon JA
    Thorax; 2017 Jun; 72(6):559-575. PubMed ID: 28115682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incidence and factors associated with active tuberculosis among people living with HIV after long-term antiretroviral therapy in Thailand: a competing risk model.
    Gatechompol S; Sophonphan J; Ubolyam S; Avihingsanon A; van Leth F; Cobelens F; Kerr SJ
    BMC Infect Dis; 2022 Apr; 22(1):346. PubMed ID: 35387594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incident tuberculosis during antiretroviral therapy contributes to suboptimal immune reconstitution in a large urban HIV clinic in sub-Saharan Africa.
    Hermans SM; Kiragga AN; Schaefer P; Kambugu A; Hoepelman AI; Manabe YC
    PLoS One; 2010 May; 5(5):e10527. PubMed ID: 20479873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors influencing treatment default among tuberculosis patients in a high burden province of South Africa.
    Kigozi G; Heunis C; Chikobvu P; Botha S; van Rensburg D
    Int J Infect Dis; 2017 Jan; 54():95-102. PubMed ID: 27894985
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
    Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The shift in tuberculosis timing among people living with HIV in the course of antiretroviral therapy scale-up in Malawi.
    Tweya H; Feldacker C; Mpunga J; Kanyerere H; Heller T; Ganesh P; Nkosi D; Kalulu M; Sinkala G; Satumba T; Phiri S
    J Int AIDS Soc; 2019 Apr; 22(4):e25240. PubMed ID: 31038836
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.